This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
INFERIOR OUTCOMES OF BASILIXIMAB COMPARE TO ANTI-THYMOCYTE GLOBULIN INDUCTION THERAPY IN KIDNEY TRANSPLANTATION WITH WEAK PRETRANSPLANT DONOR SPECIFIC ANTI-HLA ANTIBODY. Issue 3 (September 2020)
Record Type:
Journal Article
Title:
INFERIOR OUTCOMES OF BASILIXIMAB COMPARE TO ANTI-THYMOCYTE GLOBULIN INDUCTION THERAPY IN KIDNEY TRANSPLANTATION WITH WEAK PRETRANSPLANT DONOR SPECIFIC ANTI-HLA ANTIBODY. Issue 3 (September 2020)
Main Title:
INFERIOR OUTCOMES OF BASILIXIMAB COMPARE TO ANTI-THYMOCYTE GLOBULIN INDUCTION THERAPY IN KIDNEY TRANSPLANTATION WITH WEAK PRETRANSPLANT DONOR SPECIFIC ANTI-HLA ANTIBODY